CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 183 filers reported holding CARA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,000 | -6.7% | 8,302 | +55.8% | 0.00% | – |
| Q2 2023 | $15,000 | -16.7% | 5,329 | +41.7% | 0.00% | – |
| Q1 2023 | $18,000 | -75.3% | 3,761 | -45.0% | 0.00% | – |
| Q4 2022 | $73,000 | +128.1% | 6,833 | +98.2% | 0.00% | – |
| Q3 2022 | $32,000 | +28.0% | 3,447 | +23.3% | 0.00% | – |
| Q2 2022 | $25,000 | -64.3% | 2,796 | -52.0% | 0.00% | – |
| Q1 2022 | $70,000 | -39.7% | 5,828 | -39.2% | 0.00% | – |
| Q4 2021 | $116,000 | +10.5% | 9,578 | +40.5% | 0.00% | – |
| Q3 2021 | $105,000 | +22.1% | 6,819 | +12.9% | 0.00% | – |
| Q2 2021 | $86,000 | -14.9% | 6,040 | +30.1% | 0.00% | – |
| Q1 2021 | $101,000 | +140.5% | 4,644 | +67.6% | 0.00% | – |
| Q4 2020 | $42,000 | +2.4% | 2,771 | -13.8% | 0.00% | – |
| Q3 2020 | $41,000 | -26.8% | 3,213 | -0.9% | 0.00% | – |
| Q2 2020 | $56,000 | +36.6% | 3,243 | +2.8% | 0.00% | – |
| Q1 2020 | $41,000 | -49.4% | 3,155 | -36.5% | 0.00% | – |
| Q4 2019 | $81,000 | +179.3% | 4,969 | +220.6% | 0.00% | – |
| Q3 2019 | $29,000 | -23.7% | 1,550 | -12.5% | 0.00% | – |
| Q2 2019 | $38,000 | +5.6% | 1,772 | -3.9% | 0.00% | – |
| Q1 2019 | $36,000 | +56.5% | 1,843 | +5.5% | 0.00% | – |
| Q4 2018 | $23,000 | -72.0% | 1,747 | -49.2% | 0.00% | – |
| Q3 2018 | $82,000 | +6.5% | 3,439 | -14.2% | 0.00% | – |
| Q2 2018 | $77,000 | +54.0% | 4,010 | -1.9% | 0.00% | – |
| Q1 2018 | $50,000 | -36.7% | 4,089 | -37.3% | 0.00% | – |
| Q4 2017 | $79,000 | +2.6% | 6,519 | +16.6% | 0.00% | – |
| Q3 2017 | $77,000 | +140.6% | 5,591 | +165.4% | 0.00% | – |
| Q2 2017 | $32,000 | -42.9% | 2,107 | -31.3% | 0.00% | – |
| Q1 2017 | $56,000 | +211.1% | 3,069 | +57.3% | 0.00% | – |
| Q4 2016 | $18,000 | +125.0% | 1,951 | +104.1% | 0.00% | – |
| Q3 2016 | $8,000 | +60.0% | 956 | +0.1% | 0.00% | – |
| Q2 2016 | $5,000 | +66.7% | 955 | +91.0% | 0.00% | – |
| Q1 2016 | $3,000 | -62.5% | 500 | 0.0% | 0.00% | – |
| Q4 2015 | $8,000 | -42.9% | 500 | -48.8% | 0.00% | – |
| Q3 2015 | $14,000 | 0.0% | 976 | -16.9% | 0.00% | – |
| Q2 2015 | $14,000 | – | 1,174 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |